| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06714461 A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA®… |
Trial completed |
| 2026-06-12 | NCT06714461 A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA®… |
Enrollment reduced: 3500 -> 302 participants |
| 2026-06-09 | NCT07088068 A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in… |
Trial sites expanded: 153 -> 159 locations |
| 2026-06-09 | NCT07286214 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica |
Trial sites expanded: 5 -> 9 locations |
| 2026-06-06 | NCT07079670 Safety and Immunogenicity of NVX-CoV2705 |
Trial completed |
| 2026-06-06 | NCT07079670 Safety and Immunogenicity of NVX-CoV2705 |
date change Primary completion moved earlier: 2026-04-16 -> 2026-01-12 |
| 2026-06-06 | NCT07079670 Safety and Immunogenicity of NVX-CoV2705 |
date change Completion moved earlier: 2026-06-16 -> 2026-05-11 |
| 2026-06-06 | NCT07116031 A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) |
Trial sites expanded: 30 -> 33 locations |
| 2026-06-06 | NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… |
Trial sites expanded: 16 -> 23 locations |
| 2026-06-05 | NCT07086976 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib… |
Trial sites expanded: 92 -> 95 locations |
| 2026-06-04 | NCT05492578 Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous… |
Trial sites expanded: 378 -> 388 locations |
| 2026-06-03 | NCT06834360 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT06834360 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
date change Primary completion moved earlier: 2027-01-08 -> 2026-11-06 |
| 2026-06-03 | NCT06834360 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… |
date change Completion moved earlier: 2027-12-13 -> 2027-10-11 |
| 2026-06-02 | NCT07290803 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With… |
Trial sites expanded: 43 -> 56 locations |
| 2026-05-30 | NCT04401020 First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL |
Trial completed |
| 2026-05-30 | NCT07325292 Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous… |
Trial sites expanded: 24 -> 32 locations |
| 2026-05-30 | NCT07184931 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants… |
Trial sites expanded: 196 -> 259 locations |
| 2026-05-28 | NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… |
Trial sites expanded: 10 -> 15 locations |
| 2026-05-28 | NCT07457580 Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of… |
Trial sites expanded: 4 -> 11 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07634692 An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During… | Not Yet Recruiting | |
| 2026-06-05 | NCT07629336 SAR447971 First-in-human Study | Phase 1 | Recruiting |
| 2026-06-02 | NCT07621653 Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W)… | Not Yet Recruiting | |
| 2026-05-29 | NCT07612878 The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With… | Not Yet Recruiting | |
| 2026-05-29 | NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in… | Active, Not Recruiting | |
| 2026-05-29 | NCT07615179 Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD) | Active, Not Recruiting | |
| 2026-05-29 | NCT07615192 RSV Immunisation Status in Queensland (Australia) | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06671587 | iGlarLixi CGM Study in Chinese T2D Individuals After OADs | Type 2 Diabetes (T2D) | Recruiting |
| NCT06666413 | China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With… | Glycogen Storage Disease Type II | Recruiting |
| NCT07053423 | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT06145373 | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe… | Hemophilia A | Recruiting |
| NCT07286214 | Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica | Polymyalgia Rheumatica | Recruiting |
| NCT05757713 | Teplizumab in Pediatric Stage 2 Type 1 Diabetes | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| NCT07109297 | Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in… | RSV Immunization | Active, Not Recruiting |
| NCT06716424 | A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2… | Type 2 Diabetes | Active, Not Recruiting |
| NCT05983068 | A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric… | Dermatitis Atopic | Active, Not Recruiting |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline… | Asthma | Active, Not Recruiting |
| NCT07135973 | A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above… | Chronic Graft Versus Host Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT06293053 | A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6… | Prurigo Nodularis | Recruiting |
| NCT06191315 | Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic… | Wheezing | Recruiting |
| NCT07247188 | Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and… | Sickle Cell Disease | Recruiting |
| NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Ulcerative Colitis | Recruiting |
| NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With… | Sickle Cell Disease | Recruiting |
| NCT07103148 | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | Yellow Fever Immunization | Recruiting |
| NCT07184944 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Crohn's Disease | Recruiting |
| NCT07185009 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants… | Ulcerative Colitis | Recruiting |
| NCT07348692 | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy… | Pneumococcal Immunization | Recruiting |
| NCT06290128 | A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory… | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Recruiting |
| NCT07285460 | A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male… | Hemophilia | Recruiting |
| NCT07007962 | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune… | Immune Thrombocytopenia | Recruiting |
| NCT07190209 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07190222 | Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult… | Chronic Obstructive Pulmonary Disease | Recruiting |